Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: There are a trend towards increasing use of High-Flow Nasal Cannula (HFNC), outside of paediatric intensive care unit. Give this trend is necessary to update the actual evidence and to assess available published literature to determinate the efficacy of HFNC over Continuous Positive Air Pressure (CPAP) as treatment for children with severe bronchiolitis. METHODS: We searched MEDLINE, EMBASE, LILACS, and COCHRANE Central, and gray literature in clinical trials databases ( www. CLINICALTRIALS: gov ), from inception to June 2022. The inclusion criteria for the literature were randomized clinical trials (RCTs) that included children 

Original publication

DOI

10.1186/s12887-022-03754-9

Type

Journal

BMC Pediatr

Publication Date

03/12/2022

Volume

22

Keywords

Bronchiolitis, Children, Continuous positive air pressure, Continuous positive airways pressure, High flow oxygen cannula, High-flow nasal cannula, Severe bronchiolitis, Child, Humans, Child, Preschool, Cannula, Oxygen, Bronchiolitis, Continuous Positive Airway Pressure, Respiration, Artificial, Randomized Controlled Trials as Topic